Ingrid E Lundberg Selected Research

Inclusion Body Myositis

12/2021	Idiopathic inflammatory myopathies.
1/2018	Current Treatment for Myositis.
1/2018	The EuroMyositis registry: an international collaborative tool to facilitate myositis research.
1/2017	Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum.
4/2016	Disease specificity of autoantibodies to cytosolic 5'-nucleotidase 1A in sporadic inclusion body myositis versus known autoimmune diseases.
1/2016	Idiopathic inflammatory myositis.
12/2015	Patients' Experience of Myositis and Further Validation of a Myositis-specific Patient Reported Outcome Measure - Establishing Core Domains and Expanding Patient Input on Clinical Assessment in Myositis. Report from OMERACT 12.
4/2013	Low serum levels of vitamin D in idiopathic inflammatory myopathies.
3/2013	Autoantibodies to cytosolic 5'-nucleotidase 1A in inclusion body myositis.
1/2012	Autoantibodies produced at the site of tissue damage provide evidence of humoral autoimmunity in inclusion body myositis.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ingrid E Lundberg Research Topics

Disease

88	Myositis (Idiopathic Inflammatory Myopathies) 10/2022 - 11/2002
41	Dermatomyositis (Dermatopolymyositis) 11/2022 - 04/2002
32	Polymyositis 12/2021 - 04/2002
22	Inflammation (Inflammations) 11/2022 - 01/2003
13	Inclusion Body Myositis 12/2021 - 09/2007
12	Autoimmune Diseases (Autoimmune Disease) 02/2022 - 04/2013
11	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 08/2009
8	Neoplasms (Cancer) 11/2022 - 10/2009
8	Antisynthetase syndrome 12/2021 - 11/2010
7	Arthritis (Polyarthritis) 01/2022 - 11/2002
7	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021 - 01/2002
7	Muscle Weakness 01/2019 - 11/2002
5	Muscular Diseases (Myopathy) 12/2021 - 11/2002
4	Rheumatoid Arthritis 01/2018 - 11/2009
4	Pain (Aches) 01/2018 - 01/2014
4	Necrosis 01/2018 - 08/2006
3	Fever (Fevers) 11/2022 - 09/2016
3	Fatigue 11/2022 - 02/2010
3	Multiple Sclerosis 01/2019 - 02/2016
2	Deglutition Disorders (Dysphagia) 01/2022 - 01/2018
2	Lung Diseases (Lung Disease) 05/2021 - 11/2010
2	Muscular Dystrophies (Muscular Dystrophy) 01/2019 - 12/2015
2	Muscular Atrophy (Muscle Atrophy) 01/2017 - 05/2014
2	Rheumatic Diseases (Rheumatism) 01/2017 - 02/2004
2	Asthma (Bronchial Asthma) 03/2015 - 02/2004
2	Fibrosis (Cirrhosis) 03/2015 - 11/2008
2	Cardiovascular Diseases (Cardiovascular Disease) 03/2010 - 01/2005
1	Weight Loss (Weight Reduction) 11/2022
1	Osteoporosis 11/2022
1	Heart Diseases (Heart Disease) 10/2022
1	Nervous System Diseases (Neurological Disorders) 01/2022
1	Amyopathic dermatomyositis 12/2021
1	Melanoma (Melanoma, Malignant) 05/2021
1	Pulmonary Hypertension 05/2021
1	Cutaneous Lupus Erythematosus 01/2021
1	Premature Birth (Birth, Premature) 01/2020
1	Contracture 01/2019

Drug/Important Bio-Agent (IBA)

47	AutoantibodiesIBA 11/2022 - 11/2002
23	AntibodiesIBA 12/2021 - 02/2006
19	Proteins (Proteins, Gene)FDA Link 11/2022 - 11/2002
9	CytokinesIBA 01/2018 - 01/2003
8	Biomarkers (Surrogate Marker)IBA 11/2022 - 01/2009
8	Ligases (Synthetase)IBA 02/2022 - 07/2012
7	Interferon Type IIBA 01/2017 - 09/2007
6	EnzymesIBA 10/2022 - 08/2007
5	AutoantigensIBA 10/2022 - 01/2005
5	Immunoglobulin G (IgG)IBA 12/2018 - 08/2009
5	Biological ProductsIBA 01/2018 - 06/2012
4	InterferonsIBA 01/2022 - 04/2010
4	Amino Acyl-tRNA Synthetases (Aminoacyl-tRNA Synthetase)IBA 01/2022 - 08/2007
4	Creatine Kinase (Creatine Phosphokinase)IBA 01/2019 - 05/2004
4	Rituximab (Mabthera)FDA Link 01/2019 - 11/2010
4	AntigensIBA 01/2018 - 01/2002
4	InterleukinsIBA 05/2014 - 08/2006
3	ImmunosorbentsIBA 10/2022 - 01/2018
3	RNA (Ribonucleic Acid)IBA 01/2022 - 05/2006
3	GlucocorticoidsIBA 01/2022 - 10/2016
3	Transfer RNA (tRNA)IBA 05/2021 - 07/2012
3	LipidsIBA 01/2020 - 09/2003
3	Peptides (Polypeptides)IBA 01/2020 - 04/2016
3	ametantrone (HAQ)IBA 01/2018 - 11/2002
3	Messenger RNA (mRNA)IBA 01/2017 - 11/2010
3	EpitopesIBA 04/2016 - 02/2003
3	5'-Nucleotidase (5' Nucleotidase)IBA 04/2016 - 03/2013
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2006 - 02/2003
2	HLA-DR Antigens (HLA-DR)IBA 01/2019 - 02/2003
2	Abatacept (Orencia)FDA Link 01/2019 - 01/2018
2	Interleukin-18 (Interleukin 18)IBA 12/2018 - 11/2016
2	B-Cell Activating FactorIBA 01/2018 - 10/2014
2	C-Reactive ProteinIBA 01/2018 - 11/2009
2	Jo-1 antibodyIBA 01/2018 - 04/2010
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2016 - 02/2003
2	Intravenous Immunoglobulins (IVIG)FDA Link 01/2016 - 10/2007
2	Pharmaceutical PreparationsIBA 12/2015 - 09/2003
2	Triglycerides (Triacylglycerol)IBA 05/2015 - 09/2003
2	SS-A antibodiesIBA 10/2014 - 08/2006
2	LigandsIBA 10/2014 - 02/2007
2	ProstaglandinsIBA 05/2014 - 01/2014
2	HMGB1 Protein (HMG1)IBA 08/2013 - 02/2010
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2010 - 01/2007
2	Interleukin-1 (Interleukin 1)IBA 02/2007 - 05/2006
2	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2004 - 02/2004
1	Interleukin-6 (Interleukin 6)IBA 11/2022
1	Antirheumatic Agents (DMARD)IBA 11/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	Complement C4 (Complement Component 4)IBA 01/2022
1	Interleukin-16 (Interleukin 16)IBA 01/2021
1	ProteomeIBA 01/2021
1	Troponin IIBA 01/2020
1	transcriptional intermediary factor 1IBA 01/2020
1	LipopolysaccharidesIBA 01/2020
1	Interleukin-2 (IL2)IBA 01/2020
1	CD40 Ligand (CD40L)IBA 01/2020
1	Toll-Like Receptor 7IBA 10/2019
1	Epstein-Barr Virus Nuclear AntigensIBA 01/2019

Therapy/Procedure

18	Therapeutics 01/2018 - 11/2002
3	Resistance Training 03/2016 - 06/2007
2	Physical Therapy Modalities (Physical Therapy Technique) 11/2014 - 01/2014
2	Endurance Training 08/2013 - 03/2005
1	Cesarean Section (Caesarean Section) 01/2020